Women with polycystic ovary syndrome are increasingly turning to blockbuster weight-loss drugs from Eli Lilly and Novo ...

Women with polycystic ovary syndrome are increasingly turning to blockbuster weight-loss drugs from Eli Lilly and Novo ...

In a previous mouse study, the same research team found a protein in the brain called Rap1, which impacted how glucose is ...

A Thai hospital’s new fast-track dialysis protocol cut deaths from a rare metformin complication nearly in half. The study ...

A common diabetes drug could dampen some of the key benefits of exercise, a new study has found. Researchers from Rutgers University discovered that adults who took metformin, a widely used generic ...

The surprising findings could improve how doctors manage type 1 diabetes and ease the significant burden that people with the condition face when using insulin alone. In their published paper in ...

Rutgers scientists found that metformin can blunt many of the metabolic and cardiovascular improvements normally produced by exercise. Participants who took the drug saw reduced gains in fitness, ...

Dual therapy with metformin and GLP-1 RAs is associated with a lower risk for adiposity-related cancers and mortality than ...

A common diabetes drug could be sabotaging the health benefits that a patient might expect from a daily walk, a new study says. Metformin appears to blunt improvements in blood pressure, fitness and ...

Newsweek spoke to three leading specialists on the most evidence-backed ways to protect fertility: optimizing lifestyle ...

Metformin blunted exercise-induced improvements in vascular insulin sensitivity, aerobic fitness, inflammatory markers, and fasting glucose levels in adults at high risk for metabolic syndrome, ...

This is an edition of the WSJ Health newsletter, a weekly briefing on what’s new in health, medicine, personal well-being and the business of healthcare. If you’re not subscribed, sign up here. A ...